CG Oncology, Inc. Common stock (CGON) — Financial Flexibility Index
CG Oncology, Inc. Common stock (CGON) has a Financial Flexibility Index of -0.93x as of December 2025. Free cash flow of $-36.21 Million (operating CF $-36.22 Million minus capex $7.00K) represents -1% of total liabilities ($38.99 Million). Check CG Oncology, Inc. Common stock tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CG Oncology, Inc. Common stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for CG Oncology, Inc. Common stock across 5 annual periods. For the full cash flow conversion analysis, see CG Oncology, Inc. Common stock cash flow conversion.
Annual Financial Flexibility Index for CG Oncology, Inc. Common stock (2021–2025)
Year-by-year free cash flow to debt coverage for CG Oncology, Inc. Common stock. Explore CG Oncology, Inc. Common stock (CGON) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.39x | $-132.21 Million | $-132.35 Million | $38.99 Million | ▲ +7.4% |
| 2024 | -3.66x | $-78.48 Million | $-78.71 Million | $21.42 Million | ▼ -16.4% |
| 2023 | -3.15x | $-45.68 Million | $-45.68 Million | $14.51 Million | ▼ -138.5% |
| 2022 | -1.32x | $-29.79 Million | $-29.80 Million | $22.57 Million | ▼ -79.5% |
| 2021 | -0.74x | $-13.56 Million | $-13.65 Million | $18.44 Million | — |